Related Experiment Video
Updated: Oct 9, 2026

Isolation and Chemical Characterization of Lipid A from Gram-negative Bacteria
Published on: September 16, 2013
Lipopolysaccharide LPS-mediated soluble TNF receptor release and TNF receptor expression by monocytes. Role of CD14,
J F Leeuwenberg1, M A Dentener, W A Buurman
1Department of Surgery, University of Limburg, Maastricht, The Netherlands.
Abstract:
Previously we demonstrated that two soluble(s) tumor necrosis factor receptors, TNF-R55 as well as sTNF-R75, are constitutively released in vitro by monocytes, and that this release was markedly enhanced after activation. Because LPS is an important activator of monocytes, we investigated the effect of LPS on sTNF-R release by monocytes. It was found that release of sTNF-R75, but not (or minimally) release of sTNF-R55, was enhanced after activation with LPS, reaching plateau levels after approximately 2 days. CD14, one of the membrane receptors for LPS, is an intermediate in this process, as shown in experiments using mAb directed against CD14. Under serum-free conditions, LPS-induced sTNF-R75 release was less as compared with release in the presence of serum, suggesting involvement of serum proteins. Addition of LPS binding protein (LBP) enhanced the LPS-induced sTNF-R75 release under serum-free conditions, but had no effect in the presence of serum. On the other hand, bactericidal/permeability-increasing protein (BPI), known to possess LPS neutralizing activity, inhibited LPS-induced sTNF-R75 release. Furthermore, cell surface expression of both types of TNF-R was shown to be controlled by LPS, LBP, and BPI. LPS caused, within 1 h, a complete reduction of TNF-R55 as well as TNF-R75 expression, followed by enhanced re-expression of both receptors after 24 h. The down-modulation of expression was increased by LBP, whereas BPI counteracted the LPS-induced down-regulation. The LPS-enhanced release of sTNF-R75, capable of inactivation of TNF, as well as LPS-induced initial down-modulation of TNF-R expression leading to postulated temporary unresponsiveness to TNF may share in a physiological mechanism to carefully control the effects of TNF.
Insights
Lipopolysaccharide (LPS) activates monocytes to release soluble tumor necrosis factor receptor 75 (sTNF-R75), a process influenced by CD14 and serum proteins like LPS binding protein (LBP). LPS also modulates TNF-R expression, suggesting a mechanism for controlling TNF activity.
Area of Science:
- Immunology
- Cell Biology
Background:
- Soluble tumor necrosis factor receptors (sTNF-R55 and sTNF-R75) are released by monocytes and their release is enhanced upon activation.
- Lipopolysaccharide (LPS) is a key activator of monocytes.
Purpose of the Study:
- To investigate the effect of LPS on the release of sTNF-R by monocytes.
- To explore the roles of CD14, serum proteins, LPS binding protein (LBP), and bactericidal/permeability-increasing protein (BPI) in LPS-induced sTNF-R release and TNF-R expression.
Main Methods:
- Monocyte activation with LPS.
- Measurement of sTNF-R release.
- Experiments using anti-CD14 monoclonal antibodies (mAbs).
- Assessment of sTNF-R release under serum-free conditions with and without LBP or BPI.
- Analysis of cell surface TNF-R expression modulation by LPS, LBP, and BPI.
Main Results:
- LPS significantly enhanced sTNF-R75 release, but minimally affected sTNF-R55 release.
- CD14 acts as an intermediate in LPS-induced sTNF-R75 release.
- Serum proteins enhance LPS-induced sTNF-R75 release; LBP enhances it in serum-free conditions, while BPI inhibits it.
- LPS caused rapid down-modulation of cell surface TNF-R55 and TNF-R75 expression, followed by enhanced re-expression.
- LBP increased LPS-induced down-modulation, whereas BPI counteracted it.
Conclusions:
- LPS-induced sTNF-R75 release and modulation of TNF-R expression represent a physiological mechanism to regulate TNF activity.
- The findings highlight the complex interplay between LPS, its binding proteins, and monocyte receptors in controlling the inflammatory response.
More Related Videos
11:48Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
Published on: May 31, 2018
08:24Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
Related Concept Videos
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Formation of Lipopolysaccharides
Bacterial Toxins
Determinants of Bacterial Pathogenicity and Virulence